Nephrosclerosis

50
Nephrosclero sis Lecture 49 Vascular Diseases

description

Pathologic aspects

Transcript of Nephrosclerosis

Page 1: Nephrosclerosis

Nephrosclerosis

Lecture 49

Vascular Diseases

Page 2: Nephrosclerosis

Types• I. Benign Nephrosclerosis

• II. Malignant Nephrosclerosis

Page 3: Nephrosclerosis

BENIGN NEPHROSCLEROSIS

• Benign nephrosclerosis is the term used for the renal pathology associated with sclerosis (Hardening) of renal arterioles and small arteries.

• The resultant effect is focal ischemia of parenchyma supplied by vessels with

thickened walls and consequent

narrowed lumens.

Page 4: Nephrosclerosis

Benign Nephrosclerosis

The parenchymal effects include

• glomerulosclerosis and

• chronic tubulointersititial injury,

producing a reduction in functional renal mass. Hypertension and diabetes mellitus, increase the incidence and severity of the lesions.

Page 5: Nephrosclerosis

Pathogenesis Two processes participate in the arterial lesions:

• I. Medial and intimal thickening, as a response to hemodynamic changes, aging, genetic defects, or some combination of these.

The wall of a blood vessel is composed of 3 layers:

Intima, media & adventitia.

Page 6: Nephrosclerosis

PathogenesisII. Hyaline deposition in arterioles,

caused partly by extravasation of plasma proteins through injured endothelium and

partly by increased deposition of basement membrane matrix.

Page 7: Nephrosclerosis

Gross- Morphology• The kidneys are either normal or moderately

reduced in size, with average weights between 110 and 130 gm.

• The cortical surfaces have a fine, even granularity that resembles grain leather.

• The loss of mass is due mainly to cortical scarring and shrinking.

The weight of one kidney averages about 120-150 gSize: 12x 6x3 cm.

Page 8: Nephrosclerosis

Close-up of the gross appearance of the cortical surface in benign nephrosclerosis illustrating the fine, leathery

granularity of the surface.

Page 9: Nephrosclerosis

MICROSCOPYThere is

• Narrowing of the lumens of

arterioles and small arteries,

caused by thickening and hyalinization of the walls (hyaline arteriolosclerosis)

Page 10: Nephrosclerosis

Hyaline Arteriosclerosis

A fatty depositIn intima

Hyaline: A glass, pink protieinacious material

Page 11: Nephrosclerosis

Benign Nephrosclerosis: Hyaline Arteriolarsclerosis

Page 12: Nephrosclerosis
Page 13: Nephrosclerosis

MICROSCOPY• Corresponding to the fine surface granulations

are

• microscopic subcapsular scars• with sclerotic glomeruli and

• tubular dropout (Foci of tubular atrophy),

• alternating with better preserved parenchyma.

Page 14: Nephrosclerosis

MICROSCOPY• The interlobular and arcuate arteries show

a characteristic lesion that consists of

• Medial hypertrophy, • Reduplication of the elastic lamina, and

• Increased myofibroblastic tissue in the

intima,

• which combine to narrow the lumen.

Page 15: Nephrosclerosis

MICROSCOPY• This change, called fibroelastic hyperplasia• often accompanies hyalin arteriolosclerosis and

• increases in severity with AGE and

• in the presence of

HYPERTENSION.

Page 16: Nephrosclerosis

Morphology cont….

There is Patchy Ischemic Atrophy, which consists of

(1) Foci Of Tubular Atrophy and

Interstitial Fibrosis and

(2) A Variety Of Glomerular Alterations.

Page 17: Nephrosclerosis

MorphologyGlomerular alterations include:

1. Collapse Of The GBM, 2. Deposition Of Collagen Within The Bowman Space,

3. Periglomerular Fibrosis, and

4. Total Sclerosis Of Glomeruli.

Page 18: Nephrosclerosis

Morphology• When the ischemic changes

are pronounced and affect large areas of parenchyma, they can produce

regional scars.

Page 19: Nephrosclerosis

Clinical Features.

It is unusual for uncomplicated benign nephrosclerosis to cause renal insufficiency or uremia.

There are usually moderate reductions in renal blood flow, but the GFR is normal or only slightly reduced.

Page 20: Nephrosclerosis

Three groups of hypertensive patients with benign nephrosclerosis are at increased risk of developing renal failure:

1. People Of African Descent, 2. People with more severe blood pressure elevations,

3. Persons with a second underlying disease, especially diabetes.

In these groups renal insufficiency may supervene after

prolonged benign hypertension.

Page 21: Nephrosclerosis
Page 22: Nephrosclerosis

Malignant Nephrosclerosis• Malignant nephrosclerosis is the

form of Renal Disease associated with The Malignant or Accelerated Phase of

HYPERTENSION.

Page 23: Nephrosclerosis

Malignant Nephrosclerosis• Malignant hypertension may occasionally

develop in previously normotensive individuals

but often is superimposed on• Preexisting essential benign hypertension• Secondary forms of hypertension, or • An underlying chronic renal disease,

particularly glomerulonephritis or reflux nephropathy Associated with vesico-ureteric reflux

Page 24: Nephrosclerosis

Malignant Nephrosclerosis• It is also a frequent cause of death from

uremia in individuals with scleroderma. Malignant hypertension is relatively uncommon, occurring in 1% to 5% of all people with elevated blood pressure.

• In its pure form it usually affects younger individuals, and occurs more often in men and in blacks.

Page 25: Nephrosclerosis

Pathogenesis- Unclear• The basis for this turn for the worse (Zawaal)

in hypertensive subjects is

unclear, but the following sequence of events is suggested.

Page 26: Nephrosclerosis

• 1.The initial insult seems to be some form of

vascular damage to the kidneys. This might result

• from long-standing benign hypertension,

with eventual injury to the arteriolar walls, or • 2. The initiating injury may spring de novo from

arteritis,

• a coagulopathy, or • some injury causing acute exacerbation of the hypertension.

Page 27: Nephrosclerosis

Pathogenesis• In any case, the result is• 1. increased permeability of the small

vessels to fibrinogen and other plasma proteins,

• 2. endothelial injury, • 3. focal death of cells of the vascular wall,

and• 4. platelet deposition.

Page 28: Nephrosclerosis

Pathogenesis• This leads to the appearance of

1. Fibrinoid necrosis of arterioles and small arteries,

2. Swelling of the vascular intima, and

3. Intravascular Thrombosis.

Page 29: Nephrosclerosis

Pathogenesis• Mitogenic factors from platelets (e.g., PDGF),

plasma, and other cells cause hyperplasia of intimal smooth muscle of vessels, resulting in the hyperplastic arteriolosclerosis that is typical of malignant hypertension and further narrowing of the lumens.

• The kidneys become

markedly ischemic.

Page 30: Nephrosclerosis

Pathogenesis• With severe involvement of the renal

afferent arterioles, the renin-angiotensin system receives a powerful stimulus; indeed, patients with malignant hypertension have markedly elevated levels of plasma renin.

Page 31: Nephrosclerosis

Pathogenesis• This sets up a self-perpetuating cycle in which

angiotensin II causes intrarenal vasoconstriction, and the attendant renal ischemia perpetuates renin secretion.

Page 32: Nephrosclerosis

Pathogenesis• Other vasoconstrictors (e.g.,

endothelin) and loss of vasodilators (nitric oxide) may also contribute to

vasoconstriction.

Page 33: Nephrosclerosis

Pathogenesis• Aldosterone levels are also elevated,

and salt retention undoubtedly

contributes to the elevation of blood pressure.

Page 34: Nephrosclerosis

Pathogenesis• The consequences of the markedly elevated

blood pressure on the blood vessels throughout the body are known as

malignant arteriosclerosis, and

the renal disorder is malignant nephrosclerosis.

Page 35: Nephrosclerosis

Gross Morphology.

• On gross inspection the kidney size depends on the duration and severity of the hypertensive disease.

• Small, pinpoint petechial HEMORRHAGES may appear on the cortical surface from RUPTURE of arterioles or glomerular capillaries, giving the kidney a peculiar

“flea-bitten” appearance.

Page 36: Nephrosclerosis
Page 37: Nephrosclerosis

Microscopy

• Two histologic alterations characterize blood vessels in malignant hypertension:

1. Fibrinoid necrosis of arterioles.

This appears as an Eosinophilic Granular Change in the blood vessel wall, which stains positively

for fibrin by histochemical or immunofluorescence techniques.

Page 38: Nephrosclerosis

Malignant Nephrosclerosis

Page 39: Nephrosclerosis

Microscopy• This change represents an acute event; it may

be accompanied by limited inflammatory infiltrate within the wall.

• Sometimes the glomeruli become necrotic and infiltrated with neutrophils, and the glomerular capillaries may thrombose.

Page 40: Nephrosclerosis

2. In the interlobular arteries and arterioles, there is intimal thickening caused by a proliferation of elongated, concentrically arranged smooth muscle cells, together with fine concentric layering of collagen and accumulation of pale-staining material that probably represents accumulations of proteoglycans and plasma proteins. This alteration has been referred to as

onion-skinning

because of its concentric appearance.

Page 41: Nephrosclerosis

Malignant Nephrosclerosis

Page 42: Nephrosclerosis

• The lesion, also called hyperplastic arteriolitis, correlates well with renal failure in malignant hypertension.

• There may be superimposed intraluminal thrombosis.

• The arteriolar and arterial lesions result in considerable narrowing of all vascular lumens, ischemic atrophy and, at times, infarction distal to the abnormal vessels.

Page 43: Nephrosclerosis

Clinical Features• SP>200 mm Hg & DP>120 mm Hg, • Papilledema, • Retinal hemorrhages, • Encephalopathy, • Cardiovascular abnormalities, &• Renal failure.

Page 44: Nephrosclerosis

Clinical features• Most often, the early symptoms are related to

increased intracranial pressure and include• headaches,• nausea,• vomiting, and • visual impairments, particularly scotomas or spots before the eyes.

Page 45: Nephrosclerosis

Clinical Features

•Hypertensive crises are sometimes encountered, characterized by

• episodes of loss of consciousness or

even convulsions.

Page 46: Nephrosclerosis

Clinical Features• At the onset of rapidly mounting blood

pressure, there is marked proteinuria and microscopic or sometimes macroscopic

hematuria but no significant alteration in renal function.

• Soon, however, renal failure makes its appearance.

Page 47: Nephrosclerosis

Treatment• The syndrome is • a true medical emergency requiring

the institution of aggressive and prompt

antihypertensive therapy to prevent the development of irreversible renal lesions.

Page 48: Nephrosclerosis

Prognosis• Before the introduction of current

antihypertensive drugs, malignant hypertension was associated with a

• 50% mortality rate within 3 months of

onset, progressing to 90% within a year.

Page 49: Nephrosclerosis

Prognosis• At present, however, • about 75% of patients survive 5 years,

and 50% survive with restoration of pre-crisis renal function.

Page 50: Nephrosclerosis